Insider: Sepp-Lorenzino Laura EVP, Chief Scientific Officer - Intellia Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 43,927 | 0 | 43,927 |
| Value | $729,627.47 | $0.00 | $729,627.47 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/08/2024 | DDS | 667 | Direct | COM | $29.38 | $19,596.46 | 43,927 |
| 01/08/2024 | DDS | 1,608 | Direct | COM | $28.66 | $46,085.28 | 44,594 |
| 01/05/2023 | DDS | 1,641 | Direct | COM | $38.22 | $62,719.02 | 18,318 |
| 01/05/2023 | DDS | 689 | Direct | COM | $39.10 | $26,939.90 | 17,629 |
| 01/04/2023 | DDS | 2,508 | Direct | COM | $37.21 | $93,322.68 | 19,959 |
| 01/01/2022 | DDS | 1,148 | Direct | COM | $112.25 | $128,863.00 | 4,815 |
| 08/30/2021 | DDS | 16,115 | Direct | COM | $155.61 | $2,507,655.15 | 18,123 |
| 08/30/2021 | DDS | 28,669 | Direct | COM | $154.77 | $4,437,101.13 | 34,238 |
| 08/30/2021 | DDS | 20,645 | Direct | COM | $153.64 | $3,171,897.80 | 62,907 |
| 08/30/2021 | DDS | 15,839 | Direct | COM | $152.75 | $2,419,407.25 | 83,552 |
| 08/30/2021 | DDS | 7,425 | Direct | COM | $156.79 | $1,164,165.75 | 10,698 |
| 08/30/2021 | DDS | 3,932 | Direct | COM | $157.77 | $620,351.64 | 6,766 |
| 08/30/2021 | DDS | 2,653 | Direct | COM | $159.64 | $423,524.92 | 2,598 |
| 08/30/2021 | DDS | 207 | Direct | COM | $160.47 | $33,217.29 | 2,391 |
| 08/30/2021 | DDS | 1,515 | Direct | COM | $158.90 | $240,733.50 | 5,251 |
| 08/04/2021 | DDS | 6,814 | Direct | COM | $136.79 | $932,087.06 | 20,106 |
| 08/04/2021 | DDS | 1,471 | Direct | COM | $135.47 | $199,276.37 | 26,920 |
| 08/04/2021 | DDS | 6,344 | Direct | COM | $137.72 | $873,695.68 | 13,762 |
| 08/04/2021 | DDS | 4,054 | Direct | COM | $140.73 | $570,519.42 | 2,517 |
| 08/04/2021 | DDS | 126 | Direct | COM | $141.63 | $17,845.38 | 2,391 |
| 08/04/2021 | DDS | 2,772 | Direct | COM | $139.85 | $387,664.20 | 6,571 |
| 08/04/2021 | DDS | 4,419 | Direct | COM | $138.78 | $613,268.82 | 9,343 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research